- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06238804
Characteristic Analysis and Surgical Exploration for Acetabular Roof Fractures: Multicenter Retrospective Cohort Study (CASEARF)
April 7, 2024 updated by: Ruipeng Zhang, Hebei Medical University Third Hospital
Acetabular roof was a crucial structure for maintaining the stability of hip joint; however, its important role was not especially emphasized in the Letournel-Judet classification system.
Acetabular roof was segmented into the roof column and roof wall in Three-column classification and fracture in this area alone was defined as A3 injury.
Radiographic data and functional outcome of A3 injury patients were reviewed to explore the characteristics and surgical strategy.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Fracture data, surgical incision, operation time, blood loss, fracture healing, Reduction quality,functional outcome,and relevant complications
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hebei
-
Shijiazhuang, Hebei, China, 050051
- Hebei medical university third hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Patients met the inclusion criteria were collected in this study.
Description
Inclusion Criteria:
- 18-80 years, acute (<14 days) closed roof column/wall acetabular fractures (A3.1, A3.2 or A3.3) in Three-column classification, normal activity of the affected hip before the injury, received surgical reduction and internal fixation
Exclusion Criteria:
- open fractures, pathologic fractures, limited range of motion (ROM) of the hip joint before the injury, conservative treatment, risk factors affecting bone healing (such as smoking and metabolic diseases) and noncompletion of the two-year follow-up
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
fracture types
A3.1, A3.2, A3.3
|
A3.1, A3.2, A3.3
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
postoperative outcome
Time Frame: 4 months
|
Merle d'Aubigné score, fracture healing, reduction quality, etc
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
complication
Time Frame: 1 month
|
wound infection, iatrogenic injury of vessels and nerves, etc
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Zhiyong Hou, MD, Hebei medical university third hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2024
Primary Completion (Estimated)
May 1, 2024
Study Completion (Estimated)
May 1, 2024
Study Registration Dates
First Submitted
January 23, 2024
First Submitted That Met QC Criteria
January 31, 2024
First Posted (Actual)
February 2, 2024
Study Record Updates
Last Update Posted (Actual)
April 9, 2024
Last Update Submitted That Met QC Criteria
April 7, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZRP2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acetabular Fracture
-
Groupe Hospitalier Paris Saint JosephCompletedAcetabular Fracture | Acetabular SurgeryFrance
-
University of UtahEnrolling by invitation
-
National Scientific Center of Traumatology and...Recruiting
-
Assiut UniversityCompleted
-
Assiut UniversityUnknownAcetabular Fracture
-
Groupe Hospitalier Paris Saint JosephCompleted
-
University of CincinnatiRecruitingAcetabular FractureUnited States
-
Assiut UniversityNot yet recruiting
-
University Tunis El ManarCompletedAcetabular Fracture
-
University Hospital, Basel, SwitzerlandCompleted